Livdelzi (seladelpar) treats primary biliary cholangitis (PBC), a liver condition that happens when damaged bile ducts cause bile to build up. It’s a peroxisome proliferator-activated receptor (PPAR)-delta agonist that works to help the body make less bile acids. But it’s not clear yet whether it can slow liver damage in people with PBC. Livdelzi (seladelpar) is a tablet that’s taken once daily by mouth for adults. It’s taken either alone or with ursodiol (Actigall). Side effects of Livdelzi (seladelpar) include headache, dizziness, stomach pain, and bloating.
Livdelzi (seladelpar) is a peroxisome proliferator-activated receptor-delta agonist (PPAR agonist). It works by activating a protein called PPAR to help the liver produce less bile acids, which are a component of bile. This is important for people with PBC because too much bile can be harmful to the liver. Keep in mind that the exact way this helps with PBC isn’t well understood.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Contact your healthcare provider immediately if you experience any of the following.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
No. There isn’t any specific time of the day that you should take Livdelzi (seladelpar). It’s recommended that you take it around the same time every day so you don't forget.
To be safe, avoid drinking alcohol while taking Livdelzi (seladelpar). There’s no information on how alcohol affects this medication. But people with PBC already have liver damage and alcohol can put extra stress on the liver. If you drink alcohol often or have difficulty stopping, it’s important to speak with a healthcare professional. They may be able to provide additional care or support to help manage how much alcohol you drink.
You may experience side effects from Livdelzi (seladelpar), such as headaches, nausea, stomach pain, or bloating. Sometimes, over-the-counter pain medications can help relieve headaches, but talk to your pharmacist first. Nonsteroidal anti-inflammatory drugs (NSAIDs), like ibuprofen (Advil, Motrin) and naproxen (Aleve), have their own risks. And because you already have liver damage, you should avoid taking acetaminophen (Tylenol) for pain relief. Drinking plenty of water throughout the day can also help with headaches. What's more, staying hydrated can help reduce bloating. And, try taking Livdelzi (seladelpar) with food to lessen stomach upset and nausea. Contact your prescriber if you have any side effects that bother you or don’t go away.
You may not notice the effects of Livdelzi (seladelpar) right away; it doesn’t quickly relieve signs and symptoms of PBC. A study showed that people taking Livdelzi (seladelpar) had lower alkaline phosphatase (ALP) levels in as little as 1 month, and levels stayed low throughout the year. But it’s not clear whether lower ALP levels means that the PBC is improving. In the study, some people who took Livdelzi (seladelpar) also had less itching (a common symptom of liver problems) after 1 month. But the full effects on itching took around 9 months. It’s important to note that everyone's response to medications can be on different timelines. Talk to your prescriber if you have questions about how your treatment with Livdelzi (seladelpar) is going.
A study showed that most people taking Livdelzi (seladelpar) had decreased alkaline phosphatase (ALP) levels after a year of treatment. Lower ALP levels can be a sign of slower progression of PBC. But it’s not completely clear whether Livdelzi (seladelpar) really helps slow PBC. More research needs to be done to know for sure. Talk to your prescriber to learn more about how well Livdelzi (seladelpar) is working for you. They can schedule blood tests to check your ALP levels and explain what your lab results mean.
You should avoid taking medications that can interact with Livdelzi (seladelpar). Some examples include clarithromycin, diltiazem (Cardizem), furosemide (Lasix), aspirin, and pantoprazole (Protonix). These medications may raise the levels of Livdelzi (seladelpar) in the body, which can increase the risk of side effects. Review your current medication list with your pharmacist to see if any of them interact with Livdelzi (seladelpar).
If you’re pregnant or planning to become pregnant, talk to your prescriber or obstetrician-gynecologist (OB-GYN). They’ll discuss the potential risks and benefits of taking Livdelzi (seladelpar) during pregnancy. There aren’t any studies yet about whether the medication works and is safe for people who are pregnant. But there’s an ongoing study to learn more about its effect during pregnancy. If you took Livdelzi (seladelpar) while pregnant, you can enroll in this ongoing study so researchers can monitor your health outcomes. If you become pregnant while you’re taking Livdelzi (seladelpar), tell your prescriber or OB-GYN as soon as possible so they can help enroll you in the study. Also let them know what happens with your pregnancy, like if you gave birth, had any pregnancy complications, or had a miscarriage.
Livdelzi (seladelpar) and Iqirvo (elafibranor) are both approved for PBC in adults and work in similar ways as PPAR agonists. They’re both pills that are taken once daily by mouth. There aren’t any studies so far that directly compare the two medications; they’ve only been studied in separate clinical trials. In the Livdelzi trial and Iqirvo trial, both medications decreased alkaline phosphatase (ALP) levels over a year. This might mean slower PBC progression, but more research is needed to be sure. One key difference is that the Livdelzi trial also showed that the medication could improve moderate-to-severe itching (a common symptom of liver problems). But there was no significant reduction in itching in the Iqirvo trial. It’s best to talk to your prescriber if you have more questions about the differences between Livdelzi and Iqirvo.
Livdelzi (seladelpar) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
So far, people who’ve taken Livdelzi (seladelpar) at the recommended 10 mg daily dose haven’t had very large increases in their liver enzyme levels. But people who took a much higher dose (50 mg daily) did have notably higher liver enzyme levels. High liver enzyme levels could be a sign of liver stress or damage. Most times, levels returned to normal after people stopped taking the medication.
Before you start taking Livdelzi (seladelpar), you’ll need a blood test to check your liver enzyme levels. Also have these blood tests done whenever your prescriber thinks it's necessary while you’re taking the medication.
Watch for pain in the upper right side of your belly and yellowing of your skin and eyes. These can be signs and symptoms of worsening liver function or liver damage. If you notice these signs or symptoms, talk to your prescriber. They might recommend stopping Livdelzi (seladelpar) to see whether your liver health improves. But don’t stop taking the medication without checking with your prescriber first.
In clinical studies, some people who’ve taken Livdelzi (seladelpar) have experienced fractures. These fractures happened between the first 3 and 12 months of treatment.
Let your prescriber know if you have a history of fractures or osteoporosis. They might monitor your bone health during treatment. These can include tests to check your calcium levels and bone density screenings (DEXA scan).
Be mindful of the signs of a broken bone such as pain, the bone looking out of place or misshaped, bruising, and swelling. If you think you broke a bone, seek medical attention immediately and limit how much you move that bone until you get care. The healthcare team can check out the bone and talk about what to do next.
You should avoid taking Livdelzi (seladelpar) if you have a complete biliary obstruction, or a total blockage of the bile ducts. Symptoms of biliary obstruction include pain in the upper right side of your belly and yellowing of your skin and eyes. Contact your prescriber right away if you have any of these symptoms. You might have to stop Livdelzi (seladelpar) while you’re getting evaluated and treated for biliary obstruction.
| Dosage | Quantity | Price as low as | Price per unit |
|---|---|---|---|
| 10mg | 30 capsules | $12,108.01 | $403.60 |
The typical dose is 10 mg by mouth once daily.